CN102639492A - β-氨基-α-羟基酰胺的对映-和立体-有择合成 - Google Patents
β-氨基-α-羟基酰胺的对映-和立体-有择合成 Download PDFInfo
- Publication number
- CN102639492A CN102639492A CN2010800438143A CN201080043814A CN102639492A CN 102639492 A CN102639492 A CN 102639492A CN 2010800438143 A CN2010800438143 A CN 2010800438143A CN 201080043814 A CN201080043814 A CN 201080043814A CN 102639492 A CN102639492 A CN 102639492A
- Authority
- CN
- China
- Prior art keywords
- formula
- alkyl
- aryl
- benzyl
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C1C(*=C)=CCC1 Chemical compound *C1C(*=C)=CCC1 0.000 description 5
- UEWOYZVFQJKJOL-IUCAKERBSA-N CCCC[C@@H]([C@@H](C(NC1CC1)=O)O)N Chemical compound CCCC[C@@H]([C@@H](C(NC1CC1)=O)O)N UEWOYZVFQJKJOL-IUCAKERBSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- GWUFWSKCLJKBMQ-UHFFFAOYSA-N CC(C)(C)S(CC1(CCCCC1)N=C=O)(=O)=O Chemical compound CC(C)(C)S(CC1(CCCCC1)N=C=O)(=O)=O GWUFWSKCLJKBMQ-UHFFFAOYSA-N 0.000 description 1
- JSSHNVIIRICTDR-UHFFFAOYSA-N CC(C)(C)S(CC1(CCCCC1)NC(NCC=O)=O)(=O)=O Chemical compound CC(C)(C)S(CC1(CCCCC1)NC(NCC=O)=O)(=O)=O JSSHNVIIRICTDR-UHFFFAOYSA-N 0.000 description 1
- VXCGUZAPHPZAPP-LYGPFTKASA-N CC(C)(C)S(CCNC(NCC1OC1N(CCC1)[C@@H]1C(NCCC(NC1CC1)=O)=O)=O)(=O)=O Chemical compound CC(C)(C)S(CCNC(NCC1OC1N(CCC1)[C@@H]1C(NCCC(NC1CC1)=O)=O)=O)(=O)=O VXCGUZAPHPZAPP-LYGPFTKASA-N 0.000 description 1
- UEGWAUDFQVIERH-CYBMUJFWSA-N CC(C)(C)[C@@H](C(O)=O)NC(NC1(CS(C(C)(C)C)(=O)=O)CCCCC1)=O Chemical compound CC(C)(C)[C@@H](C(O)=O)NC(NC1(CS(C(C)(C)C)(=O)=O)CCCCC1)=O UEGWAUDFQVIERH-CYBMUJFWSA-N 0.000 description 1
- UBNIQRMMHYVQKR-UHFFFAOYSA-N CCCC(C)S(CC1(CCCCC1)N)(=O)=O Chemical compound CCCC(C)S(CC1(CCCCC1)N)(=O)=O UBNIQRMMHYVQKR-UHFFFAOYSA-N 0.000 description 1
- SCFBBLWFBPWTCL-RDPSFJRHSA-N CCCC[C@@H](CC(NC1CC1)=O)N(Cc1ccccc1)[C@@H](C)c1ccccc1 Chemical compound CCCC[C@@H](CC(NC1CC1)=O)N(Cc1ccccc1)[C@@H](C)c1ccccc1 SCFBBLWFBPWTCL-RDPSFJRHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N OC(C1NCCC1)=O Chemical compound OC(C1NCCC1)=O ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/04—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides onto unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22963609P | 2009-07-29 | 2009-07-29 | |
| US22961309P | 2009-07-29 | 2009-07-29 | |
| US22961809P | 2009-07-29 | 2009-07-29 | |
| US22965209P | 2009-07-29 | 2009-07-29 | |
| US22964809P | 2009-07-29 | 2009-07-29 | |
| US61/229,648 | 2009-07-29 | ||
| US61/229,652 | 2009-07-29 | ||
| US61/229,636 | 2009-07-29 | ||
| US61/229,613 | 2009-07-29 | ||
| US61/229,618 | 2009-07-29 | ||
| PCT/US2010/043356 WO2011014494A1 (en) | 2009-07-29 | 2010-07-27 | ENANTIO- AND STEREO-SPECIFIC SYNTHESES OF β-AMINO-α- HYDROXY AMIDES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102639492A true CN102639492A (zh) | 2012-08-15 |
Family
ID=42753493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010800438143A Pending CN102639492A (zh) | 2009-07-29 | 2010-07-27 | β-氨基-α-羟基酰胺的对映-和立体-有择合成 |
Country Status (12)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115160205A (zh) * | 2022-07-08 | 2022-10-11 | 上海皓鸿生物医药科技有限公司 | 一种制备(s)-1-(叔丁氧羰基)-2,5-二氢-1h-吡咯-2-羧酸及盐的方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101076516A (zh) * | 2004-02-27 | 2007-11-21 | 先灵公司 | 作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的硫化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4825129B2 (ja) | 2003-06-17 | 2011-11-30 | シェーリング コーポレイション | (1r,2s,5s)−6,6−ジメチル−3−アザビシクロ[3,1,0]ヘキサン−2−カルボキシレートまたはその塩の調製のためのプロセスおよび中間体 |
| CN100450585C (zh) * | 2004-04-07 | 2009-01-14 | K·I化成株式会社 | 包括硫化氢和硫醇等硫化物的除去方法 |
| US7834190B2 (en) * | 2006-05-26 | 2010-11-16 | Kaneka Corporation | Process for production of optically active-3-amino-2-hydroxypropionic cyclopropylamide derivatives and salts thereof |
| DE102006059317A1 (de) * | 2006-07-04 | 2008-01-10 | Evonik Degussa Gmbh | Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden |
-
2010
- 2010-07-27 EA EA201270223A patent/EA022038B1/ru unknown
- 2010-07-27 US US13/387,619 patent/US8680294B2/en active Active
- 2010-07-27 IN IN346DEN2012 patent/IN2012DN00346A/en unknown
- 2010-07-27 SG SG2012005658A patent/SG178115A1/en unknown
- 2010-07-27 CA CA2768838A patent/CA2768838A1/en not_active Abandoned
- 2010-07-27 JP JP2012522958A patent/JP2013500971A/ja not_active Withdrawn
- 2010-07-27 CN CN2010800438143A patent/CN102639492A/zh active Pending
- 2010-07-27 AU AU2010276490A patent/AU2010276490B2/en not_active Ceased
- 2010-07-27 WO PCT/US2010/043356 patent/WO2011014494A1/en active Application Filing
- 2010-07-27 GE GEAP201012594A patent/GEP20207101B/en unknown
- 2010-07-27 EP EP10737726.9A patent/EP2459525B1/en active Active
- 2010-07-28 AR ARP100102733A patent/AR077506A1/es not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101076516A (zh) * | 2004-02-27 | 2007-11-21 | 先灵公司 | 作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的硫化合物 |
Non-Patent Citations (1)
| Title |
|---|
| ASHOK ARASAPPAN,ET AL.: "Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor", 《ACS MEDICINAL CHEMISTRY LETTERS》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115160205A (zh) * | 2022-07-08 | 2022-10-11 | 上海皓鸿生物医药科技有限公司 | 一种制备(s)-1-(叔丁氧羰基)-2,5-二氢-1h-吡咯-2-羧酸及盐的方法 |
| CN115160205B (zh) * | 2022-07-08 | 2024-06-07 | 上海皓鸿生物医药科技有限公司 | 一种制备(s)-1-(叔丁氧羰基)-2,5-二氢-1h-吡咯-2-羧酸及盐的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2459525B1 (en) | 2017-03-01 |
| AU2010276490B2 (en) | 2013-11-14 |
| US8680294B2 (en) | 2014-03-25 |
| US20120178942A1 (en) | 2012-07-12 |
| IN2012DN00346A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-05-08 |
| EP2459525A1 (en) | 2012-06-06 |
| AU2010276490A1 (en) | 2012-03-08 |
| CA2768838A1 (en) | 2011-02-03 |
| EA201270223A1 (ru) | 2012-07-30 |
| AR077506A1 (es) | 2011-08-31 |
| WO2011014494A1 (en) | 2011-02-03 |
| JP2013500971A (ja) | 2013-01-10 |
| GEP20207101B (en) | 2020-05-11 |
| SG178115A1 (en) | 2012-03-29 |
| GEAP202012594A (en) | 2020-01-27 |
| EA022038B1 (ru) | 2015-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2645362C (en) | Synthesis of acylaminoalkenylene amides useful as substance p antagonists | |
| FI112472B (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen atsaheterosyklikarboksyylihappojen valmistamiseksi | |
| US20060199958A1 (en) | Process and intermediates for the preparation of pyrrolidine carboxylic acids | |
| JP3665343B2 (ja) | α−ハロケトン、α−ハロヒドリン及びエポキシドの製造法 | |
| US20040180933A1 (en) | Process for preparing 1,2-diamino compounds | |
| EP3237379B1 (en) | Process for preparing alpha-carboxamide pyrrolidine derivatives | |
| CN102639492A (zh) | β-氨基-α-羟基酰胺的对映-和立体-有择合成 | |
| US8431733B2 (en) | Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives | |
| JPS6351358A (ja) | ジタ−シヤリ−ブチルジカ−ボネ−トの製法 | |
| JPH06102639B2 (ja) | アミノ酸誘導体 | |
| WO2024092892A1 (zh) | 依度沙班中间体及其制备方法 | |
| US20050222456A1 (en) | Synthesis of cyclohexanone derivatives | |
| US7456302B2 (en) | Method for producing pentacyclic taxans | |
| AU3877899A (en) | Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 | |
| US20090312571A1 (en) | Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives | |
| JP2002520306A (ja) | N−第3−ブチルヒドロキシルアミンの新規な塩 | |
| EP1362845B1 (fr) | Nouveau procédé de synthèse des esters de la N-((S)-1-carboxybutyl)-(S)-alanine et application à la synthèse du perindopril | |
| JP4699582B2 (ja) | 1h−4(5)−アミノイミダゾール−5(4)−カルボキサミドの製造方法 | |
| CN115557871B (zh) | 一种抗病毒化合物pf-07321332的合成方法 | |
| CN116813518A (zh) | 一种奈玛特韦手性中间体的合成方法 | |
| WO2000002862A1 (en) | Retroviral protease inhibitors | |
| JP3547749B2 (ja) | (s)−1−[2(s)−(1,3−ジヒドロ−1,3−ジオキソ−イソインド−2−イル)−1−オキソ−3−フェニルプロピル]−1,2,3,4−テトラヒドロ−2−ピリジン−カルボン酸メチルエステル及びその中間体類の新規な製法 | |
| WO2023175526A1 (en) | Process for preparation of azabicyclo [3.1.0] hexane intermediates | |
| KR100518933B1 (ko) | 옥사졸린-아제티디논 유도체의 정제방법 | |
| EP0643046A1 (fr) | Acides et chlorures d'acides 1,2,3,4-tétrahydroquinoléine-8-sulfoniques, comme intermédiaires |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: new jersey Applicant after: Schering Corporation Address before: new jersey Applicant before: SCHERING CORP (US) |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SCHERING CORP (US) TO: MSD CORP. |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120815 |